Principal Financial Group Inc Axsome Therapeutics, Inc. Transaction History

Principal Financial Group Inc

$167 Billion
Q1 2025

A detailed history of Principal Financial Group Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 295,671 shares of AXSM stock, worth $29.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

295,671

Previous 207,065 42.79%

Holding current value

$29.8 Million

Previous $17.5 Million 96.84%

% of portfolio

0.02%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 28, 2025	BUY	$80.05 - $137.75 $7.09 Million - $12.2 Million	88,606 Added 42.79%	295,671 $34.5 Million
Q4 2024 Jan 31, 2025	BUY	$83.08 - $100.49 $17.2 Million - $20.8 Million	207,065 New	207,065 $17.5 Million
Q3 2024 Oct 31, 2024	SELL	$78.93 - $95.84 $249,497 - $302,950	-3,161 Reduced 48.23%	3,393 $304,000
Q2 2024 Jul 29, 2024	SELL	$65.72 - $80.5 $211,552 - $259,129	-3,219 Reduced 32.94%	6,554 $527,000
Q1 2024 Apr 29, 2024	BUY	$69.39 - $97.64 $19,151 - $26,948	276 Added 2.91%	9,773 $779,000
Q4 2023 Feb 07, 2024	BUY	$57.42 - $83.61 $6,890 - $10,033	120 Added 1.28%	9,497 $755,000
Q3 2023 Nov 02, 2023	SELL	$69.25 - $82.21 $2.37 Million - $2.81 Million	-34,164 Reduced 78.46%	9,377 $655,000
Q2 2023 Aug 07, 2023	BUY	$58.41 - $90.35 $1.98 Million - $3.06 Million	33,821 Added 347.95%	43,541 $3.13 Million
Q1 2023 May 09, 2023	SELL	$58.39 - $75.0 $35,501 - $45,600	-608 Reduced 5.89%	9,720 $599,000
Q4 2022 Feb 09, 2023	BUY	$39.94 - $79.72 $67,658 - $135,045	1,694 Added 19.62%	10,328 $796,000
Q3 2022 Nov 09, 2022	SELL	$36.06 - $69.85 $1,875 - $3,632	-52 Reduced 0.6%	8,634 $385,000
Q2 2022 Aug 10, 2022	BUY	$21.74 - $46.75 $78,220 - $168,206	3,598 Added 70.72%	8,686 $333,000
Q1 2022 May 09, 2022	BUY	$23.7 - $41.39 $120,585 - $210,592	5,088 New	5,088 $211,000
Q4 2021 Feb 09, 2022	SELL	$30.7 - $43.36 $227,732 - $321,644	-7,418 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$19.91 - $68.26 $112,411 - $385,395	-5,646 Reduced 43.22%	7,418 $244,000
Q2 2021 Aug 10, 2021	SELL	$50.63 - $73.5 $57,262 - $83,128	-1,131 Reduced 7.97%	13,064 $881,000
Q1 2021 May 10, 2021	SELL	$55.91 - $81.44 $29,185 - $42,511	-522 Reduced 3.55%	14,195 $804,000
Q4 2020 Feb 08, 2021	BUY	$66.31 - $86.52 $212,059 - $276,690	3,198 Added 27.76%	14,717 $1.2 Million
Q3 2020 Nov 06, 2020	SELL	$68.34 - $85.84 $36,015 - $45,237	-527 Reduced 4.37%	11,519 $820,000
Q2 2020 Aug 05, 2020	BUY	$49.87 - $98.69 $333,031 - $659,051	6,678 Added 124.4%	12,046 $991,000
Q1 2020 May 12, 2020	SELL	$41.2 - $101.31 $88,868 - $218,525	-2,157 Reduced 28.66%	5,368 $316,000
Q4 2019 Feb 05, 2020	BUY	$16.71 - $106.24 $125,742 - $799,456	7,525 New	7,525 $777,000

Others Institutions Holding AXSM

# of Institutions

406

Shares Held

36.2M

Call Options Held

751K

Put Options Held

568K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.32B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Axsome Therapeutics, Inc. Transaction History